Published by Coherent Market Insights
Posted on September 16, 2021
3 min readLast updated: February 9, 2026
Add as preferred source on Google
Erectile Dysfunction Devices Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Meda Pharmaceuticals, Inc., Coloplast, Global Life Technologies, Reflexonic, LLC, Augusta Medical Systems, and Boston Scientific Corporation.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/27
North America is expected to hold the major share in the global erectile dysfunction devices market and this is attributed to the continuous innovation in the device by key players in the region. For instance, in July 2019, Boston Scientific announced the launch of the Tactra penile implant, which is a durable implant with a natural feel for treating ED. Also, in August 2019, Ohio, U.S.-based Integrated Medical announced that they are offering a state-of-the-art Extra Corporeal Shock Wave Therapy (ESWT) for treating ED. The therapy will utilize power generated through acoustic sound waves and radial shockwaves to stimulate neovascularization
The growing prevalence of cardiovascular or diabetes disease among men undergoing such treatment are at higher risk of developing erectile dysfunction. This is driving the growth of the erectile dysfunction devices market. Vacuum pumps, also known as Vacuum Erection devices (VED) are gaining huge demand around the globe. According to the National Health Services, nine out of ten men using vacuum pumps are able to have sex regardless of the underlying cause of ED. Penile implants are medicated devices, which further requires research on their efficacy and safety. Rising awareness regarding treatment and increasing disposable income of consumers across developing countries is again fostering the growth of the market.
In January 2017, Boston Sci launched a new erectile dysfunction device. The newly launched implant has enough potential advantages over existing erectile dysfunction treatment implants
In December 2020, Glenmark Pharma has received final approval from the US health regulator for Tadalafil tablets, used to treat erectile dysfunction and enlarged prostate.
In November 2018, Zydus Cadila has launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the American market.
Erectile Dysfunction Devices is the most sought erectile dysfunction treatment nowadays. There are countless erectile dysfunction devices available in the market that promise lasting results, fast-acting results, minimal side effects, superlative performance, and best of all, cost-effectiveness. Vacuum constrictors, penis pumps, and penis injections are some of the erectile dysfunction devices available today in the market. Some erectile dysfunction devices have gained such popularity that most men tend to opt for a treatment method based on user-friendliness and ease of usage rather than basing their choice on price or brand preference. One of the most promising areas in the erectile dysfunction Devices market is the growing awareness among people about ED.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/27
Reasons to Purchase this Report
• Current and future of global Erectile Dysfunction Devices Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Erectile Dysfunction Devices Market Is Highly Competitive And Vibrant With The Major Key Players appeared first on Gatorledger.
The growing prevalence of cardiovascular or diabetes disease among men undergoing treatment is driving the growth of the erectile dysfunction devices market.
North America is expected to hold the major share in the global erectile dysfunction devices market due to continuous innovation by key players in the region.
In December 2020, Glenmark Pharma received final approval from the US health regulator for Tadalafil tablets, and in November 2018, Zydus Cadila launched generic Vardenafil Hydrochloride tablets in the American market.
Key players in the global erectile dysfunction devices market include Meda Pharmaceuticals, Coloplast, Global Life Technologies, Reflexonic, Augusta Medical Systems, and Boston Scientific.
The newly launched implants, such as the one by Boston Scientific in January 2017, have potential advantages over existing erectile dysfunction treatment implants, enhancing their effectiveness.
Explore more articles in the Research Reports category
